Table 1 Demographics of the cohort (N = 29)
ANBP-L (N = 12) | ANBP (N = 17) | t-test (DF) | p value | |
|---|---|---|---|---|
Admission demographics | ||||
BMI (kg/m2) | 13.6 (2.3) | 13.3 (1.2) | 0.37 (27) | 0.71 |
%IBW | 65.1 (11.1) | 64.3 (6.3) | 0.25 (27) | 0.81 |
Age (yrs) | 33.3 (10.4) | 28.6 (9.3) | 1.26 (27) | 0.22 |
Duration of eating disorder (yrs) | 18.4 (9.2) | 14.7 (9.5) | 1.03 (27) | 0.31 |
Discharge kcals | 3,217 (600.0) | 3,124 (373.0) | 0.52 (27) | 0.61 |
kg/week gained | 2.3 (0.7) | 2.0 (0.7) | 0.9 (27) | 0.38 |
Admission laboratory values (reference range) | ||||
Carbon dioxide (18–27 mmol/L) | 22.8 (4.7) | 30.5 (6.3) | -3.62 (27) | 0.001 |
Potassium (3.6–5.1 mmol/L) | 3.6 (0.7) | 3.4 (0.7) | 1.05 (27) | 0.3 |
Sodium (135–143 mmol/L) | 132.8 (7.5) | 136.8 (5.3) | -1.69 (27) | 0.1 |
Creatinine (0.6–1.2 mg/dL) | 1.2 (0.8) | 0.9 (0.3) | 1.31 (12.9) | 0.21 |
Count (%) | Count (%) | |||
Female | 11 (92) | 17 (100) | ||
Edema development | 10 (91) | 14 (82) | ||
Type of laxative used | ||||
Pills | 9 (82%) | |||
Tea | 0 | |||
Enema | 0 | |||
Suppository | 1 (9%) | |||
Active ingredient of laxative used | ||||
Bisacodyl | 9 (82%) | |||
Senna | 4 (36%) | |||
Sodium picosulfate | 2 (18%) | |||
Castor oil | 0 | |||
Other | 0 | |||